iQure Pharma Inc.

New Filing
CIK: 0001996977·Pharmaceuticals·DELAWARE·Filed: Oct 11, 2023
Total Offering

$2,000,000

Amount Sold

$1,500,000

Investors

13

First Sale

Oct 4, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2019
Non-Accredited Investors
No

Related Persons

NameRole
Pawel Zolnierczyk
Related Person

Company

iQure Pharma Inc.

3 KITTANSETT COURT

SKILLMAN, NJ, 08558

3127411606

SEC Filing

0001996977-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
iQure Pharma Inc. Form D Filing — $2,000,000 | FilingFlow